Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies announced after the close of the market on Monday that it is planning a public offering of 4.5 million shares of its common stock.

The company itself will offer and sell 2.5 million shares, while one of its stockholders, Clarus Lifesciences, will offer and sell the other 2 million shares. NanoString also said it will grant the underwriters a 30-day option to purchase up to 675,000 additional shares. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.